Цель: изучить безопасность и эффективность использования препарата бивалирудин
у пациентов с ОКС с подъемом сегмента ST. Материалы и методы: в исследование …

… DTI bivalirudin, which has been extensively studied for use in the management of acute
coronary syndrome (ACS) with and without ST-segment … role of bivalirudin and DTIs in general. …

… We report on a case of non-ST-segment myocardial infarction … ), we intravenously administered
bivalirudin instead of LMWH … Our observations may draw attention to bivalirudin therapy …

… After applying the exclusion criteria, the final sample consisted of 64,872 patients (Figure
1). … received any bivalirudin, and investigated whether a hospital's quartile of bivalirudin use …

… to high risk unstable angina and non-ST segment elevation myocardial infarction to three
different anticoagulation strategies including bivalirudin with provisional GpIIb/IIIa inhibition, …

… Heparin monotherapy versus bivalirudin monotherapy has not been evaluated in a major
trial in a dedicated non–ST-segment elevation myocardial infarction (NSTEMI) population …

Objective ST-segment elevation myocardial infarction (STEMI) is the most serious type of
acute coronary syndrome. This study aimed to investigate the efficacy and safety of bivalirudin …

… online by a web application presented in the interface of the Swedish coronary angiography
and angioplasty registry to receive intravenous administration of bivalirudin (Angiox, The …

… The individual major outcomes were also in favour of bivalirudin in … bivalirudin, there did
not appear to be any increased risk of ischaemic events. The benefit associated with bivalirudin …

… At multivariate logistic regression analysis, intracoronary bivalirudin bolus administration
emerged as an independent predictor of complete ST segment recovery, angiographically …